Literature DB >> 24947559

Surrogacy assessment using principal stratification and a Gaussian copula model.

Asc Conlon1, Jmg Taylor1, M R Elliott1,2.   

Abstract

In clinical trials, a surrogate outcome ( S) can be measured before the outcome of interest ( T) and may provide early information regarding the treatment ( Z) effect on T. Many methods of surrogacy validation rely on models for the conditional distribution of T given Z and S. However, S is a post-randomization variable, and unobserved, simultaneous predictors of S and T may exist, resulting in a non-causal interpretation. Frangakis and Rubin developed the concept of principal surrogacy, stratifying on the joint distribution of the surrogate marker under treatment and control to assess the association between the causal effects of treatment on the marker and the causal effects of treatment on the clinical outcome. Working within the principal surrogacy framework, we address the scenario of an ordinal categorical variable as a surrogate for a censored failure time true endpoint. A Gaussian copula model is used to model the joint distribution of the potential outcomes of T, given the potential outcomes of S. Because the proposed model cannot be fully identified from the data, we use a Bayesian estimation approach with prior distributions consistent with reasonable assumptions in the surrogacy assessment setting. The method is applied to data from a colorectal cancer clinical trial, previously analyzed by Burzykowski et al.

Entities:  

Keywords:  Gaussian copula; causal inference; potential outcomes; surrogate endpoint

Mesh:

Substances:

Year:  2016        PMID: 24947559      PMCID: PMC4272338          DOI: 10.1177/0962280214539655

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  15 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes.

Authors:  G Molenberghs; H Geys; M Buyse
Journal:  Stat Med       Date:  2001-10-30       Impact factor: 2.373

3.  The validation of surrogate endpoints in meta-analyses of randomized experiments.

Authors:  M Buyse; G Molenberghs; T Burzykowski; D Renard; H Geys
Journal:  Biostatistics       Date:  2000-03       Impact factor: 5.899

4.  ASSESSING SURROGATE ENDPOINTS IN VACCINE TRIALS WITH CASE-COHORT SAMPLING AND THE COX MODEL.

Authors:  Li Qin; Peter B Gilbert; Dean Follmann; Dongfeng Li
Journal:  Ann Appl Stat       Date:  2008-03       Impact factor: 2.083

5.  Surrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal.

Authors:  Anna S C Conlon; Jeremy M G Taylor; Michael R Elliott
Journal:  Biostatistics       Date:  2013-11-26       Impact factor: 5.899

6.  On the relationship between response to treatment and survival time.

Authors:  M Buyse; P Piedbois
Journal:  Stat Med       Date:  1996-12-30       Impact factor: 2.373

7.  Surrogate endpoints in clinical trials: definition and operational criteria.

Authors:  R L Prentice
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

8.  A Bayesian approach to improved estimation of causal effect predictiveness for a principal surrogate endpoint.

Authors:  Corwin M Zigler; Thomas R Belin
Journal:  Biometrics       Date:  2012-02-20       Impact factor: 2.571

9.  Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.

Authors:  P Piedbois; P Rougier; M Buyse; J Pignon; L Ryan; R Hansen; B Zee; B Weinerman; J Pater; C Leichman; J Macdonald; J Benedetti; J Lokich; J Fryer; G Brufman; R Isacson; A Laplanche; E Levy
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

10.  Surrogate endpoints in clinical trials: cancer.

Authors:  S Ellenberg; J M Hamilton
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

View more
  3 in total

1.  Evaluating surrogate marker information using censored data.

Authors:  Layla Parast; Tianxi Cai; Lu Tian
Journal:  Stat Med       Date:  2017-01-15       Impact factor: 2.373

2.  Surrogacy assessment using principal stratification with multivariate normal and Gaussian copula models.

Authors:  Jeremy M G Taylor; Anna S C Conlon; Michael R Elliott
Journal:  Clin Trials       Date:  2014-12-09       Impact factor: 2.486

3.  BAYESIAN METHODS FOR MULTIPLE MEDIATORS: RELATING PRINCIPAL STRATIFICATION AND CAUSAL MEDIATION IN THE ANALYSIS OF POWER PLANT EMISSION CONTROLS.

Authors:  Chanmin Kim; Michael J Daniels; Joseph W Hogan; Christine Choirat; Corwin M Zigler
Journal:  Ann Appl Stat       Date:  2019-10-17       Impact factor: 2.083

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.